A method of providing a patient with controlled release of tapentadol using a prodrug capable, upon enzymatic activation and intramolecular cyclization, of releasing tapentadol is disclosed. The disclosure also provides such prodrug compounds and pharmaceutical compositions comprising such compounds. Such pharmaceutical compositions can optionally include an enzyme inhibitor that interacts with the enzyme(s) to mediate the enzymatically-controlled release of tapentadol from the prodrug so as to modify enzymatic cleavage of the prodrug. Also included are methods to use such compounds and pharmaceutical compositions.
本发明揭示了一种利用一种可在酶催化下内分子环化释放tapentadol的前药来为患者提供控制释放tapentadol的方法。该披露还提供了这样的前药化合物和包含这样的化合物的制药组合物。这样的制药组合物可以选择性地包括与酶相互作用以调节从前药释放tapentadol的酶控制释放的酶
抑制剂,以修改前药的酶解。还包括使用这样的化合物和制药组合物的方法。